References
1. Lippi G, Sanchis-Gomar F, Cervellin
G. Global epidemiology of atrial fibrillation: An increasing epidemic
and public health challenge. Int J Stroke . Feb
2021;16(2):217-221. doi:10.1177/1747493019897870
2. Ganesan AN, Chew DP, Hartshorne T,
et al. The impact of atrial fibrillation type on the risk of
thromboembolism, mortality, and bleeding: a systematic review and
meta-analysis. Eur Heart J . May 21 2016;37(20):1591-602.
doi:10.1093/eurheartj/ehw007
3. January CT, Wann LS, Calkins H, et
al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline
for the Management of Patients With Atrial Fibrillation: A Report of the
American College of Cardiology/American Heart Association Task Force on
Clinical Practice Guidelines and the Heart R. Circulation .
2019;140(2)doi:10.1161/cir.0000000000000665
4. Turagam MK, Musikantow D, Whang W,
et al. Assessment of Catheter Ablation or Antiarrhythmic Drugs for
First-line Therapy of Atrial Fibrillation. JAMA Cardiology .
2021;6(6):697. doi:10.1001/jamacardio.2021.0852
5. Zhao Y, Krupadev V, Dagher L, et
al. Pharmacological rhythm versus rate control in patients with atrial
fibrillation and heart failure: the CASTLE-AF trial. J Interv Card
Electrophysiol . Sep 2021;61(3):609-615. doi:10.1007/s10840-020-00856-1
6. Packer DL, Mark DB, Robb RA, et al.
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality,
Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial
Fibrillation. JAMA . 2019;321(13):1261. doi:10.1001/jama.2019.0693
7. Blomström-Lundqvist C, Gizurarson
S, Schwieler J, et al. Effect of Catheter Ablation vs Antiarrhythmic
Medication on Quality of Life in Patients With Atrial Fibrillation.JAMA . 2019;321(11):1059. doi:10.1001/jama.2019.0335
8. Hindricks G, Potpara T, Dagres N,
et al. 2020 ESC Guidelines for the diagnosis and management of atrial
fibrillation developed in collaboration with the European Association
for Cardio-Thoracic Surgery (EACTS). European Heart Journal .
2021;42(5):373-498. doi:10.1093/eurheartj/ehaa612
9. Gaynor SL, Diodato MD, Prasad SM,
et al. A prospective, single-center clinical trial of a modified Cox
maze procedure with bipolar radiofrequency ablation. The Journal
of Thoracic and Cardiovascular Surgery . 2004;128(4):535-542.
doi:10.1016/j.jtcvs.2004.02.044
10. Badhwar V, Rankin JS, Damiano RJ,
et al. The Society of Thoracic Surgeons 2017 Clinical Practice
Guidelines for the Surgical Treatment of Atrial Fibrillation. The
Annals of Thoracic Surgery . 2017;103(1):329-341.
doi:10.1016/j.athoracsur.2016.10.076
11. Ad N, Damiano RJ, Badhwar V, et
al. Expert consensus guidelines: Examining surgical ablation for atrial
fibrillation. The Journal of Thoracic and Cardiovascular Surgery .
2017;153(6):1330-1354.e1. doi:10.1016/j.jtcvs.2017.02.027
12. Calkins H, Hindricks G, Cappato
R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on
catheter and surgical ablation of atrial fibrillation: Executive
summary. Europace . Jan 1 2018;20(1):157-208.
doi:10.1093/europace/eux275
13. McCarthy PM, Davidson CJ, Kruse
J, et al. Prevalence of atrial fibrillation before cardiac surgery and
factors associated with concomitant ablation. The Journal of
Thoracic and Cardiovascular Surgery . 2020;159(6):2245-2253.e15.
doi:10.1016/j.jtcvs.2019.06.062
14. Bhargava M, Di Biase L, Mohanty
P, et al. Impact of type of atrial fibrillation and repeat catheter
ablation on long-term freedom from atrial fibrillation: Results from a
multicenter study. Heart Rhythm . 2009;6(10):1403-1412.
doi:10.1016/j.hrthm.2009.06.014
15. Chao T-F, Tsao H-M, Lin Y-J, et
al. Clinical Outcome of Catheter Ablation in Patients With Nonparoxysmal
Atrial Fibrillation. Circulation: Arrhythmia and
Electrophysiology . 2012;5(3):514-520. doi:10.1161/circep.111.968032
16. Mansour M, Calkins H, Osorio J,
et al. Persistent Atrial Fibrillation Ablation With Contact
Force-Sensing Catheter: The Prospective Multicenter PRECEPT Trial.JACC Clin Electrophysiol . Aug 2020;6(8):958-969.
doi:10.1016/j.jacep.2020.04.024
17. Su WW, Reddy VY, Bhasin K, et al.
Cryoballoon ablation of pulmonary veins for persistent atrial
fibrillation: Results from the multicenter STOP Persistent AF trial.Heart Rhythm . 2020;17(11):1841-1847.
doi:10.1016/j.hrthm.2020.06.020
18. Tsai T-Y, Lo L-W, Cheng W-H, et
al. 10-Year Outcomes of Patients With Non-Paroxysmal Atrial Fibrillation
Undergoing Catheter Ablation. Circulation Journal .
2022;doi:10.1253/circj.cj-22-0062
19. Shrestha S, Plasseraud KM, Makati
K, et al. Hybrid Convergent ablation for atrial fibrillation: A
systematic review and meta-analysis. Heart Rhythm O2 . Aug
2022;3(4):396-404. doi:10.1016/j.hroo.2022.05.006
20. Mannakkara NN, Porter B, Child N,
et al. Convergent Ablation for Persistent Atrial Fibrillation: Outcomes
from a Single-Center Real-world Experience. Eur J Cardiothorac
Surg . Nov 8 2022;doi:10.1093/ejcts/ezac515
21. Wats K, Kiser A, Makati K, et al.
The Convergent Atrial Fibrillation Ablation Procedure: Evolution of a
Multidisciplinary Approach to Atrial Fibrillation Management.Arrhythm Electrophysiol Rev . Aug 2020;9(2):88-96.
doi:10.15420/aer.2019.20
22. Kress DC. Characterizing
Recurrence Following Hybrid Ablation in Patients With Persistent Atrial
Fibrillation. Journal of Patient-Centered Research and Reviews .
2020;7(3):227-238.
23. Makati KJ, Sherman AJ,
Gerogiannis I, Sood N. Safety and Efficacy of Convergent Hybrid
Procedure Using Cryo as Endocardial Energy Source for the Treatment of
Atrial Fibrillation. Circ Arrhythm Electrophysiol . Nov
2020;13(11):e008556. doi:10.1161/CIRCEP.120.008556
24. DeLurgio DB, Crossen KJ, Gill J,
et al. Hybrid Convergent Procedure for the Treatment of Persistent and
Long-Standing Persistent Atrial Fibrillation: Results of CONVERGE
Clinical Trial. Circ Arrhythm Electrophysiol . Dec
2020;13(12):e009288. doi:10.1161/CIRCEP.120.009288
25. Yang F, Tiano J, Mittal S,
Turakhia M, Jacobowitz I, Greenberg Y. Towards a Mechanistic
Understanding and Treatment of a Progressive Disease: Atrial
Fibrillation. Journal of Atrial Fibrillation .
2017;10(3)doi:10.4022/jafib.1627
26. Tilz RR, Rillig A, Thum A-M, et
al. Catheter Ablation of Long-Standing Persistent Atrial Fibrillation.Journal of the American College of Cardiology .
2012;60(19):1921-1929. doi:10.1016/j.jacc.2012.04.060
27. Clarnette JA, Brooks AG, Mahajan
R, et al. Outcomes of persistent and long-standing persistent atrial
fibrillation ablation: a systematic review and meta-analysis.Europace . Nov 1 2018;20(FI_3):f366-f376.
doi:10.1093/europace/eux297
28. Delurgio DB, Blauth C, Halkos ME,
et al. Hybrid epicardial-endocardial ablation for long-standing
persistent atrial fibrillation: a subanalysis of the CONVERGE trial.Heart Rhythm O2 . 2022;doi:10.1016/j.hroo.2022.11.007
29. Maclean E, Yap J, Saberwal B, et
al. The convergent procedure versus catheter ablation alone in
longstanding persistent atrial fibrillation: A single centre,
propensity-matched cohort study. International Journal of
Cardiology . 2020;303:49-53. doi:10.1016/j.ijcard.2019.10.053
30. Zhuang J, Wang Y, Tang K, et al.
Association between left atrial size and atrial fibrillation recurrence
after single circumferential pulmonary vein isolation: a systematic
review and meta-analysis of observational studies. Europace . May
2012;14(5):638-45. doi:10.1093/europace/eur364
31. Njoku A, Kannabhiran M, Arora R,
et al. Left atrial volume predicts atrial fibrillation recurrence after
radiofrequency ablation: a meta-analysis. Europace . Jan 1
2018;20(1):33-42. doi:10.1093/europace/eux013
32. DeLurgio DB, Gill JS, Ahsan S,
Kaba RA, Plasseraud KM, Halkos ME. Hybrid Convergent Procedure for the
Treatment of Persistent and Long-standing Persistent Atrial
Fibrillation. Arrhythm Electrophysiol Rev . Oct
2021;10(3):198-204. doi:10.15420/aer.2021.24
33. Santhanakrishnan R, Wang N,
Larson MG, et al. Atrial Fibrillation Begets Heart Failure and Vice
Versa. Circulation . 2016;133(5):484-492.
doi:10.1161/circulationaha.115.018614
34. Anter E, Jessup M, Callans DJ.
Atrial Fibrillation and Heart Failure. Circulation .
2009;119(18):2516-2525. doi:10.1161/circulationaha.108.821306
35. Noseworthy PA, Van Houten HK,
Gersh BJ, et al. Generalizability of the CASTLE-AF trial: Catheter
ablation for patients with atrial fibrillation and heart failure in
routine practice. Heart Rhythm . Jul 2020;17(7):1057-1065.
doi:10.1016/j.hrthm.2020.02.030
36. Marrouche NF, Brachmann J,
Andresen D, et al. Catheter Ablation for Atrial Fibrillation with Heart
Failure. New England Journal of Medicine . 2018;378(5):417-427.
doi:10.1056/nejmoa1707855
37. Kiankhooy A, Pierce C, Burk S,
Phillips A, Eisenberg S, Dunnington G. Hybrid Ablation of Persistent and
Long-Standing Persistent Atrial Fibrillation with Depressed Ejection
Fraction: A Single Center Observational Study. JTCVS Open .
2022;doi:10.1016/j.xjon.2022.08.014
38. Di Biase L, Burkhardt JD, Mohanty
P, et al. Left Atrial Appendage. Circulation .
2010;122(2):109-118. doi:10.1161/circulationaha.109.928903
39. Lee LS. Subxiphoid Minimally
Invasive Epicardial Ablation (Convergent Procedure) With Left
Thoracoscopic Closure of the Left Atrial Appendage. Operative
Techniques in Thoracic and Cardiovascular Surgery . December 1, 2018
2019;23(4):152-165.
doi:https://doi.org/10.1053/j.optechstcvs.2019.04.002
40. Ranjan R, Kaba R, Chandrasekaran
V, Momin A. The Convergent Ablation and AtriClip Exclusion of the Left
Atrial Appendage in Long-Standing Persistent Atrial Fibrillation.Clinical Medicine Insights: Case Reports .
2022;15:117954762211207. doi:10.1177/11795476221120778
41. Gegechkori N. The Effect of Left
Atrial Appendage Closure on Patients Undergoing Hybrid / Convergent
Atrial Fibrillation Ablation. Original Research. Journal of Atrial
Fibrillation & Electrophysiology . June-July 2022 2022;15(4):66-71.
42. Marshall J. On the Development of
the Great Anterior Veins in Man and Mammalia; Including an Account of
Certain Remnants of Foetal Structure Found in the Adult, a Comparative
View of These Great Veins in the Different Mammalia, and an Analysis of
Their Occasional Peculiarities in the Human Subject. Philosophical
Transactions of the Royal Society of London . 1850;140:133-170.
43. Rodríguez-Mañero M, Schurmann P,
Valderrábano M. Ligament and vein of Marshall: A therapeutic opportunity
in atrial fibrillation. Heart Rhythm . 2016;13(2):593-601.
doi:10.1016/j.hrthm.2015.10.018
44. Jiang R-H. Marked Suppression of
Pulmonary Vein Firing After Circumferential Pulmonary Vein Isolation in
Patients with Paroxysmal Atrial Fibrillation: Is Pulmonary Vein Firing
an Epiphenomenon? Original Article. Journal of Cardiovascular
Electrophysiology . 2014;25(2):111-118.
doi:https://doi.org/10.1111/jce.12288
45. Katritsis DG, Pokushalov E,
Romanov A, et al. Autonomic denervation added to pulmonary vein
isolation for paroxysmal atrial fibrillation: a randomized clinical
trial. J Am Coll Cardiol . Dec 17 2013;62(24):2318-25.
doi:10.1016/j.jacc.2013.06.053
46. Wong CX, Ganesan AN, Selvanayagam
JB. Epicardial fat and atrial fibrillation: current evidence, potential
mechanisms, clinical implications, and future directions. Eur
Heart J . May 1 2017;38(17):1294-1302. doi:10.1093/eurheartj/ehw045
47. Valderrábano M, Peterson LE,
Swarup V, et al. Effect of Catheter Ablation With Vein of Marshall
Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial
Fibrillation. JAMA . 2020;324(16):1620.
doi:10.1001/jama.2020.16195
48. Kumar P, Bamimore AM, Schwartz
JD, et al. Challenges and Outcomes of Posterior Wall Isolation for
Ablation of Atrial Fibrillation. Journal of the American Heart
Association . 2016;5(9):e003885. doi:10.1161/jaha.116.003885
49. Pothineni NVK, Lin A, Frankel DS,
et al. Impact of left atrial posterior wall isolation on arrhythmia
outcomes in patients with atrial fibrillation undergoing repeat
ablation. Heart Rhythm O2 . 2021;2(5):489-497.
doi:10.1016/j.hroo.2021.07.004